Gerber Kawasaki Wealth & Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,119
Closed -$427K 594
2021
Q3
$427K Buy
+6,119
New +$430K 0.06% 113
2020
Q3
Sell
-31,296
Closed -$2.41M 134
2020
Q2
$2.41M Sell
31,296
-3,381
-10% -$259K 0.53% 42
2020
Q1
$2.59M Buy
+34,677
New +$2.4M 0.74% 35
2018
Q4
Sell
-3,241
Closed -$252K 120
2018
Q3
$252K Sell
3,241
-1,217
-27% -$91.9K 0.07% 111
2018
Q2
$317K Buy
4,458
+66
+2% +$4.66K 0.09% 79
2018
Q1
$331K Sell
4,392
-1,387
-24% -$110K 0.11% 79
2017
Q4
$414K Sell
5,779
-1,882
-25% -$143K 0.14% 74
2017
Q3
$628K Sell
7,661
-4,269
-36% -$326K 0.23% 65
2017
Q2
$826K Sell
11,930
-8,787
-42% -$585K 0.31% 62
2017
Q1
$1.38M Sell
20,717
-12,218
-37% -$859K 0.59% 42
2016
Q4
$2.36M Sell
32,935
-52,139
-61% -$3.88M 1.24% 28
2016
Q3
$6.73M Sell
85,074
-37,139
-30% -$3.02M 3.9% 5
2016
Q2
$10.2M Sell
122,213
-4,700
-4% -$417K 6.43% 3
2016
Q1
$11.7M Buy
126,913
+7,218
+6% +$651K 8.05% 3
2015
Q4
$12.1M Buy
+119,695
New +$12.5M 8.2% 3

Other funds holding GILD

Gerber Kawasaki Wealth & Investment Management's GILD Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 6,119 shares — an estimated $427K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in GILD in Q4 2015 and held it in 15 quarters. The position peaked at $12.1M in Q4 2015. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 6,119 Gilead Sciences shares in Q4 2021, an estimated $427K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Gilead Sciences in Q4 2015 and held it in 15 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Gilead Sciences position peaked at $12.1M in Q4 2015.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.